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The differences between Escherichia coli strains associated with symptomatic and asymptomatic urinary tract infections (UTIs)
remain to be properly determined. Here we examined the prevalence of plasmid types and bacteriocins, as well as genetic related-
ness, in a defined collection of E. coli strains that cause UTIs. Comparative analysis identified a subgroup of strains with a high
number of virulence genes (VGs) andmicrocins M/H47.We also identified associations betweenmicrocin genes, VGs, and spe-
cific plasmid types.
Urinary tract infections (UTIs) are among the most commoninfectious diseases of humans (17). Uropathogenic Esche-
richia coli (UPEC) is the major etiological agent of UTIs and can
cause both symptomatic infection and asymptomatic bacteriuria
(ABU) in catheterized (CA-ABU) and noncatheterized patients
with ABU. Two recent studies identified and compared the viru-
lence gene (VG) carriage of E. coli strains isolated from patients
with ABU, CA-ABU, and symptomatic UTIs (13, 21). However,
the prevalence of plasmid types and bacteriocins and the genetic
relatedness of these strains were not elucidated. Here we have
examined these features in the same set of E. coli strains that cause
UTIs by determining the prevalence of different plasmid incom-
patibility types and sequence types (STs), the distribution of coli-
cin andmicrocin genes, and their random amplified polymorphic
DNA (RAPD) profile.
A collection of 159 UTI-causing E. coli strains consisting of 51
ABU, 62 CA-ABU, and 44 symptomatic UTI-causing strains
(comprising 25 pyelonephritis and 19 cystitis strains) were used in
this study (13, 21). The ABU prototype strain 83972 (2, 11) and
the ABU E. coli reference strain (ECOR) 71 were also used in this
study. All strains have been previously characterized for the
prevalence of 18 VGs and Clermont phylogenetic groups (13,
21). These data were used for the comparative analysis with
plasmid types and bacteriocins and RAPD analysis in this
study. DNA extraction from the isolates was performed as pre-
viously described (1).
Plasmid replicon typing was carried out to investigate the pres-
ence of 18 replicons using three multiplex panels (5, 8). The pres-
ence of the following 16 bacteriocins was assessed by multiplex
PCRs: colicins A, B, D, E1, E2, E3, E6, E7, Ia/Ib, K, M, and V and
microcins B17, H47, J25, and M. The PCR primers and pools are
described in Table S1 in the supplemental material. The genetic
relatedness of theUTI-causing strains was assessed by RAPD anal-
ysis using primer 1254 (CCGCAGCCAA) (14). The prevalence of
the three most common STs (ST69, ST95, and ST131) associated
with E. coliUTIs were also investigated using previously described
methods (3, 7). Comparisons of prevalence among the different
groups of E. coli were analyzed using the 2 test (n  5) and
Fisher’s exact test (n  5) using SPSS (version 17) software. The
likelihood ratio 2 and Kappa () index was used to quantify the
degree of coassociation between genes.
Plasmid typing revealed 14 different plasmid replicons, with
84% of the strains carrying at least one plasmid replicon (Table 1
and Fig. 1). The most common plasmid replicons identified were
Inc FIB (present in 103/159 strains [65%]) and Frep FII, FIII, FIV,
and FV variants of IncF (present in 108/159 strains [68%]). The
B/O plasmid replicon was more prevalent in symptomatic UTI
strains (23%) than in ABU strains (8%; P 0.0342), while the FIB
replicon was more prevalent in CA-ABU strains (74%) than in
ABU strains (51%) (P  0.0098). None of the strains contained
the Inc A/C, T, K/B, and H12 plasmid replicons.
No significant difference was observed in the prevalence of
bacteriocin genes between ABU, CA-ABU, and symptomatic UTI
strains. Bacteriocin genes were detected in 56% of strains; 29% of
strains contained colicin genes, and 38% contained microcin
genes.MicrocinM (31%) andH47 (30%) and colicin Ia/Ib (14%),
E1 (12%), andV (11%)were themost commonbacteriocin genes.
Colicins A, D, E2, and E6 were not detected in any of the strains.
The cooccurrence of bacteriocin genes was also examined (see
Table S2 in the supplemental material). A significant coassocia-
tion of microcinM andH47 genes was identified (likelihood ratio
2 122.254 and P 0.0001). Out of the 49 strains that harbored
the microcin M gene, 43 strains (88%) also carried microcin H47
gene. A similar coassociation was observed between colicin V and
Ia/Ib (likelihood ratio 2  84.545 and P  0.0001). Microcin
genes were more prevalent in strains belonging to phylogenetic
group B2 (53% [P 0.003]) compared to strains in groups A and
B1 (33%) and D (22%).
RAPD analysis resolved 3 major clusters with 60% band simi-
larity and 7 independent branches with 70% band similarity (see
Fig. S1 in the supplemental material). There was a strong correla-
tion between RAPD profiling and phylogenetic group typing. The
likelihood of each phylogenetic group clustering together on the
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basis of RAPD profiles was as follows: B2, 2  49.5 and P 
0.0001; D, 2 41.1 and P 0.0001; A, 2 9.0 and P 0.041;
B1, 2 9.15 and P 0.076.
The analysis of the three common STs revealed that ST95
(14%) was more common than ST131 (6%) and ST69 (not de-
tected). All of the ST95 and ST131 isolates were identified as B2
strains. The ST95 strains were significantly associated with strains
causing symptomatic UTIs (27%) compared to strains causing
ABU (8%; P 0.009) and CA-ABU (10%; P 0.0174). A signif-
icant coassociation of colicin V and Ia/Ib genes was also observed
in the ST95 strains (likelihood ratio 2  28.4 and P  0.0001)
(see Table S2 in the supplemental material). None of the ST131
strains contained any bacteriocin genes tested for in this study
(Fig. 1).
Cluster analysis usingVGs, bacteriocin genes, andplasmid rep-
licon types separated a group of strains (cluster 1) harboring a
large number of VGs (median score of 9VGs). Cluster 1 contained
55 strains with a substantial mix from all the three UTI groups
(27% of ABU, 42% CA-ABU, and 31% of symptomatic UTI
strains).The strains in this cluster belonged predominantly to
phylogenetic group B2 (95%). All of the strains in cluster 1 con-
tained the iroN gene, while the majority of strains contained the
toxin genes hlyA (93%) and cnf1 (91%) and F1C fimbrial gene
focG (97%). Forty-seven strains in cluster 1 contained the micro-
cin M gene; 87% of these strains also contained the microcin H47
gene. A significant coassociation of the microcin M/H47 genes
with hlyA, cnf1, focG, and iroN was also observed (see Table S2 in
the supplementalmaterial). Overall, themajor difference between
TABLE 1 Distribution of bacteriocins, plasmid replicons, and phylogenetic groups among E. coli strains causing ABU, CA-ABU, and
symptomatic UTIs
Gene or replicon
No. of strains (%) causing: Statistical significance of prevalencea
ABU (n 53) CA-ABU (n 62) Symptomatic UTI (n 44) ABU vs CA-ABU
ABU vs
symptomatic UTI
CA-ABU vs
symptomatic UTI
Plasmid replicons
B/O 4 (8) 10 (16) 10 (23) NS 0.0342 NS
FIC 1 (2) 0 (0) 0 (0) NS NS NS
P 0 (0) 1 (2) 0 (0) NS NS NS
W 2 (4) 0 (0) 0 (0) NS NS NS
FIIA 1 (2) 2 (3) 0 (0) NS NS NS
FIA 6 (11) 7 (11) 4 (9) NS NS NS
FIB 27 (51) 46 (74) 30 (68) 0.0098 NS NS
Y 5 (9) 0 (0) 1 (2) 0.0187 NS NS
I1 3 (6) 5 (8) 4 (9) NS NS NS
Frep 30 (57) 49 (79) 29 (66) 0.0097 NS NS
X 0 (0) 2 (3) 0 (0) NS NS NS
HI1 0 (0) 3 (5) 2 (5) NS NS NS
N 2 (4) 2 (3) 1 (2) NS NS NS
L/M 0 (0) 0 (0) 1 (2) NS NS NS
Bacteriocins
Colicins
B 2 (4) 1 (2) 0 (0) NS NS NS
E1 6 (11) 10 (16) 3 (7) NS NS NS
E3 1 (2) 0 (0) 0 (0) NS NS NS
E7 2 (4) 0 (0) 0 (0) NS NS NS
K 1 (2) 2 (3) 4 (9) NS NS NS
Ia/Ib 6 (11) 9 (15) 7 (16) NS NS NS
M 1 (2) 1 (2) 0 (0) NS NS NS
Microcins
V 6 (11) 5 (8) 6 (14) NS NS NS
B17 2 (4) 4 (6) 1 (2) NS NS NS
H47 12 (23) 23 (37) 12 (27) NS NS NS
M 15 (28) 22 (35) 12 (27) NS NS NS
J25 0 (0) 2 (3) 0 (0) NS NS NS
Sequence types
ST95 4 (8) 6 (10) 12 (27) NS 0.0090 0.0174
ST131 2 (4) 4 (7) 4 (9) NS NS NS
ST69 0 (0) 0 (0) 0 (0) NS NS NS
Phylogenetic groups
A 5 (9) 6 (10) 1 (2) NS NS NS
B1 3 (6) 2 (3) 1 (2) NS NS NS
B2 37 (70) 44 (71) 34 (77) NS NS NS
D 8 (15) 10 (16) 8 (18) NS NS NS
aNS, not statistically significant.
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FIG 1 Cluster analysis based on VGs, bacteriocins, plasmid types, and sequence types created using Jaccard correlation and complete linkage. The dendrogram
shows theRAPDprofiles of each isolate.Green, purple, and red represent strains causing symptomaticUTI, ABU, andCA-ABU, respectively. Bacterial strains and
their respective phylogenetic groups are also indicaated.
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strains in cluster 1 and clusters 2 to 5 was the presence of the
microcin M/H47 genes.
Bacteriocin gene analysis revealed that microcin genes were
more prevalent than colicin genes. A coassociation of microcin
M/H47 and colicin V and Ia/Ib was observed. The isolates that
carriedmicrocinM/H47 predominantly belonged to phylogenetic
group B2. The isolates that possessedmicrocinM/H47 genes were
also associated with the carriage of a greater number of VGs (me-
dian VG score of 9) compared to the isolates that did not carry
M/H47 genes (median score of 5 VGs). Cluster analysis using all
three markers (VG, bacteriocins, and plasmid replicons) (Fig. 1)
demonstrated that microcinM/H47 carrying isolates shared a VG
profile that was distinct from all other strains. This was further
supported by the RAPD analysis, which revealed that there was
minimal genetic diversity within this cluster in comparison to
strains that lacked theM/H47microcin genes (Fig. 1). One isolate
in this cluster belonged to the ST131 lineage, and three isolates
belonged to the ST95 lineage (7, 15, 18, 20). Taken together, the
data suggest that the group of strains that formed cluster 1 are
genetically distinct from other strains examined in this study.
A highly significant coassociation between the M/H47 micro-
cin genes and hlyA, cnf1, focG, and iroN was observed among the
strains in cluster 1. Previous reports have shown that these genes
are often located on the same pathogenicity island (PAI) (12, 16,
19), and this would also explain our data. In addition, PAI-
CFT073-serX contains themicrocinM/H47 gene cluster, F1Cfim-
brial genes, and the iro gene cluster (4). The genetic arrangement
of these genes in the strains examined in this study remains to be
determined.
The comprehensive genotyping employed in this study could
not clearly differentiate the E. coli strains based on clinical UTI
types. Many of the ABU strains were similar to CA-ABU and
symptomatic UTI strains based on RAPD patterns, VG profiling,
bacteriocins, and plasmid types. Interestingly, we identified ABU
and CA-ABU strains that possessed similar properties to the pro-
totype ABU E. coli strain 83972 (2, 9, 11). This suggests that atten-
uation of ABU and CA-ABU strains through gene loss and/or
mutation may be a common occurrence (9, 10, 22).
Plasmid typing revealed differences in the prevalence of plas-
mids among the E. coli strains based on UTI severity. There was a
high prevalence of FIB plasmids in the CA-ABU and symptomatic
UTI strains; these conjugative plasmids have also been shown to
contribute to biofilm formation (6). Further investigation into the
dissemination of specific plasmid types and their involvement in
virulence and antibiotic resistance is necessary to understand the
epidemiology of UTI-causing E. coli.
In summary, this study identified a cluster of similar UTI-
causing E. coli strains associated with symptomatic and asymp-
tomatic UTIs. The association betweenmicrocin and VGs, as well
as the high prevalence of specific plasmid types,might reflect char-
acteristics associated with an enhanced ability to colonize the uri-
nary tract.
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